Over two-thirds of biopharmaceutical manufacturers now report that their facility is experiencing capacity bottlenecks due to downstream processing. A number of factors continue to converge to create ...
Many recombinant viral vectors for expression of ectopic antigens mimic a natural infection and can induce a robust immune response against certain pathogens and tumors. Host-restricted poxviruses and ...
As titers rise, the mass of the protein increases, but so does the downstream load. If a resin has a low Dynamic Binding Capacity (DBC), manufacturers are forced to use larger columns or more cycles, ...
Osmolality is a well-established parameter for upstream bioprocessing, formulation, analytical development and QC applications throughout the manufacturing of biological drugs. A recent publication ...
With the recent FDA approval of the CAR T-cell therapies Kymriah ® from Novartis and Yescarta ® from Kite Pharma, there has been a renewed interest in bioprocessing and the manufacturing facilities ...
Dublin, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The "Downstream Processing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's ...
The pursuit of Biosimilars, Antibody-Drug Conjugates and New Processing Technologies will set the trend for biomanufacturing in 2013; so says research from the industry's leading conference and ...
Standards organization says R2v3 certification entails accurately portraying operations of facilities receiving components and materials. SERI says qualifications for a non-R2v3 downstream vendor are ...
Finalized on Mar. 1, the purchase includes Lindsey refinery, the Finaline pipeline, and the Killingholme loading terminal, together with shares in joint venture (JV) operations, Prax said. “Our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results